Literature DB >> 23294084

Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury.

Johnny D Figueroa1, Kathia Cordero, Miguel S Llán, Marino De Leon.   

Abstract

Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) confer multiple health benefits and decrease the risk of neurological disorders. Studies are needed, however, to identify promising cellular targets and to assess their prophylactic value against neurodegeneration. The present study (1) examined the efficacy of a preventive diet enriched with ω-3 PUFAs to reduce dysfunction in a well-established spinal cord injury (SCI) animal model and (2) used a novel metabolomics data analysis to identify potential neurolipidomic targets. Rats were fed with either control chow or chow enriched with ω-3 PUFAs (750 mg/kg/day) for 8 weeks before being subjected to a sham or a contusion SCI operation. We report new evidence showing that rats subjected to SCI after being pre-treated with a diet enriched with ω-3 PUFAs exhibit significantly better functional outcomes. Pre-treated animals exhibited lower sensory deficits, autonomic bladder recovery, and early improvements in locomotion that persisted for at least 8 weeks after trauma. We found that SCI triggers a robust alteration in the cord PUFA neurolipidome, which was characterized by a marked docosahexaenoic acid (DHA) deficiency. This DHA deficiency was associated with dysfunction and corrected with the ω-3 PUFA-enriched diet. Multivariate data analyses revealed that the spinal cord of animals consuming the ω-3 PUFA-enriched diet had a fundamentally distinct neurolipidome, particularly increasing the levels of essential and long chain ω-3 fatty acids and lysolipids at the expense of ω-6 fatty acids and its metabolites. Altogether, dietary ω-3 PUFAs prophylaxis confers resiliency to SCI mediated, at least in part, by generating a neuroprotective and restorative neurolipidome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23294084      PMCID: PMC3660112          DOI: 10.1089/neu.2012.2718

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  88 in total

1.  Molecular evidence of repair and plasticity following spinal cord injury.

Authors:  Daniel K Resnick; Caroline Schmitt; Gurwattan S Miranpuri; Vinay K Dhodda; Jason Isaacson; Raghu Vemuganti
Journal:  Neuroreport       Date:  2004-04-09       Impact factor: 1.837

Review 2.  Recovery of locomotion after spinal cord injury: some facts and mechanisms.

Authors:  Serge Rossignol; Alain Frigon
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

3.  Coordination of the bladder detrusor and the external urethral sphincter in a rat model of spinal cord injury: effect of injury severity.

Authors:  V Pikov; J R Wrathall
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 4.  Control of locomotion in vertebrates: spinal and supraspinal mechanisms.

Authors:  S Grillner; R Dubuc
Journal:  Adv Neurol       Date:  1988

5.  Expression and activation of ephexin is altered after spinal cord injury.

Authors:  Odrick R Rosas; Johnny D Figueroa; Aranza I Torrado; Mónica Rivera; José M Santiago; Franchesca Konig-Toro; Jorge D Miranda
Journal:  Dev Neurobiol       Date:  2011-07       Impact factor: 3.964

Review 6.  A systematic review of directly applied biologic therapies for acute spinal cord injury.

Authors:  Brian K Kwon; Elena B Okon; Ward Plunet; Darryl Baptiste; Karim Fouad; Jessica Hillyer; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-06-16       Impact factor: 5.269

7.  Dietary alpha-linolenic acid deficiency in adult rats for 7 months does not alter brain docosahexaenoic acid content, in contrast to liver, heart and testes.

Authors:  J M Bourre; O S Dumont; M J Piciotti; G A Pascal; G A Durand
Journal:  Biochim Biophys Acta       Date:  1992-03-04

8.  A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury.

Authors:  W L Huang; V R King; O E Curran; S C Dyall; R E Ward; N Lal; J V Priestley; A T Michael-Titus
Journal:  Brain       Date:  2007-09-27       Impact factor: 13.501

9.  Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo.

Authors:  Ying Gao; Kangwen Deng; Jianwei Hou; J Barney Bryson; Angel Barco; Elena Nikulina; Tim Spencer; Wilfredo Mellado; Eric R Kandel; Marie T Filbin
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

Review 10.  Phospholipase A2 and its molecular mechanism after spinal cord injury.

Authors:  Nai-Kui Liu; Xiao-Ming Xu
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.682

View more
  22 in total

1.  Fatty Acid Binding Protein 5 Modulates Docosahexaenoic Acid-Induced Recovery in Rats Undergoing Spinal Cord Injury.

Authors:  Johnny D Figueroa; Miguel Serrano-Illan; Jenniffer Licero; Kathia Cordero; Jorge D Miranda; Marino De Leon
Journal:  J Neurotrauma       Date:  2016-03-29       Impact factor: 5.269

2.  Metabolomics and Precision Medicine in Trauma: The State of the Field.

Authors:  Sudha P Jayaraman; Rahul J Anand; Jonathan H DeAntonio; Martin Mangino; Michel B Aboutanos; Vigneshwar Kasirajan; Rao R Ivatury; Alex B Valadka; Olena Glushakova; Ronald L Hayes; Lorin M Bachmann; Gretchen M Brophy; Daniel Contaifer; Urszula O Warncke; Donald F Brophy; Dayanjan S Wijesinghe
Journal:  Shock       Date:  2018-07       Impact factor: 3.454

3.  Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features.

Authors:  Fabio J Pacheco; Frankis G Almaguel; Whitney Evans; Leslimar Rios-Colon; Valery Filippov; Lai S Leoh; Elizabeth Rook-Arena; Melanie Mediavilla-Varela; Marino De Leon; Carlos A Casiano
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

4.  Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury.

Authors:  J D Figueroa; K Cordero; M Serrano-Illan; A Almeyda; K Baldeosingh; F G Almaguel; M De Leon
Journal:  Neuroscience       Date:  2013-09-14       Impact factor: 3.590

5.  Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury.

Authors:  Johnny D Figueroa; Marino De Leon
Journal:  Mol Neurobiol       Date:  2014-04-17       Impact factor: 5.590

6.  Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain, and Spinal Cord.

Authors:  Hylde Zirpoli; Chuchun L Chang; Yvon A Carpentier; Adina T Michael-Titus; Vadim S Ten; Richard J Deckelbaum
Journal:  Annu Rev Nutr       Date:  2020-09-23       Impact factor: 11.848

Review 7.  Nutritional Health Considerations for Persons with Spinal Cord Injury.

Authors:  Gregory Bigford; Mark S Nash
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

8.  A Single Bolus of Docosahexaenoic Acid Promotes Neuroplastic Changes in the Innervation of Spinal Cord Interneurons and Motor Neurons and Improves Functional Recovery after Spinal Cord Injury.

Authors:  Zhuo-Hao Liu; Ping K Yip; Louise Adams; Meirion Davies; Jae Won Lee; Gregory J Michael; John V Priestley; Adina T Michael-Titus
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

Review 9.  Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.

Authors:  Grace Y Sun; Agnes Simonyi; Kevin L Fritsche; Dennis Y Chuang; Mark Hannink; Zezong Gu; C Michael Greenlief; Jeffrey K Yao; James C Lee; David Q Beversdorf
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-03-10       Impact factor: 3.015

Review 10.  Dietary Supplementation for Para-Athletes: A Systematic Review.

Authors:  Keely A Shaw; Gordon A Zello; Brian Bandy; Jongbum Ko; Leandy Bertrand; Philip D Chilibeck
Journal:  Nutrients       Date:  2021-06-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.